Provided is a technology of inhibiting a change in color of a halogenated isoquinoline derivative-containing aqueous composition during storage at high temperature. This pharmaceutical preparation comprises an aqueous composition which contains a compound represented by general formula (1) [where, X represents a halogen atom] or a salt thereof, or a solvate thereof, and which is contained in a polyolefin resin container.
